Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.96
0.00 (0.00%)
At close: Aug 15, 2025, 2:35 PM

Gossamer Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
46.07M 32.11M 111.97M 183.4M
Short-Term Investments
248.44M 264.32M 143.71M 141.81M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
283K 618K 680K 1.08M
Receivables
5.34M n/a n/a n/a
Inventory
n/a n/a n/a -136K
Other Current Assets
10.03M 10.09M 6.2M 264K
Total Current Assets
309.89M 306.52M 261.88M 331.78M
Property-Plant & Equipment
5.12M 4.78M 9.89M 10.8M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
5.4M 5.4M 10.57M 11.88M
Total Assets
315.29M 311.92M 272.45M 343.66M
Account Payables
2.32M 5.53M 1.46M 3.24M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 11.61M 11.61M n/a
Other Current Liabilities
30.7M 10.29M 1.00 2.38M
Total Current Liabilities
45.01M 51.6M 49.23M 39.86M
Long-Term Debt
197.52M 197.41M 207.7M 179.12M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
240.79M 197.55M 211.14M 182.34M
Total Liabilities
285.8M 249.15M 260.37M 222.19M
Total Debt
202.88M 212.46M 225.74M 185.24M
Common Stock
23K 23K 10K 8K
Retained Earnings
-1.27B -1.21B -1.03B -811.53M
Comprehensive Income
1.19M -350K -574K 45K
Shareholders Equity
29.49M 62.77M 12.08M -811.53M
Total Investments
248.44M 264.32M 143.71M 141.81M